$Regeneron Pharmaceuticals (REGN.US)$REGN has an ORR of 71% ...

Yemaozi commented on a stock · Feb 22 13:16

$Regeneron Pharmaceuticals(REGN.US)$REGN has an ORR of 71% of refractory cancers, and regenerative pharmaceutical bispecific antibodies have been granted priority review by the FDA.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

29K Views

Comment

Yemaozi

63Followers

17Following

411Visitors